Dr Andrew James Zganjar, MD | |
4500 San Pablo Rd S, Jacksonville, FL 32224-1865 | |
(904) 953-2000 | |
Not Available |
Full Name | Dr Andrew James Zganjar |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 9 Years |
Location | 4500 San Pablo Rd S, Jacksonville, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235524018 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Mayo Clinic Florida | Jacksonville, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mayo Clinic - Florida | 5698689297 | 1310 |
News Archive
The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years. This is one of the deadliest cancers, with a five-year survival rate of only 20 percent. However, the survival rate more than doubles if the cancer is identified early.
Microbiology researchers at the University of Georgia studying a soil bacterium have identified a potential mechanism for neurodegenerative diseases.
[Many doctors] are giving up ownership of their practices to become part of hospital-owned practices or larger groups with multiple specialties. ... Young doctors in particular are choosing to work for larger organizations rather than starting their own practices, they say.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
› Verified 5 days ago
Entity Name | Mayo Clinic Jacksonville |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790772317 PECOS PAC ID: 5698689297 Enrollment ID: O20031118000388 |
News Archive
The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years. This is one of the deadliest cancers, with a five-year survival rate of only 20 percent. However, the survival rate more than doubles if the cancer is identified early.
Microbiology researchers at the University of Georgia studying a soil bacterium have identified a potential mechanism for neurodegenerative diseases.
[Many doctors] are giving up ownership of their practices to become part of hospital-owned practices or larger groups with multiple specialties. ... Young doctors in particular are choosing to work for larger organizations rather than starting their own practices, they say.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrew James Zganjar, MD 4500 San Pablo Rd S, Jacksonville, FL 32224-1865 Ph: (904) 953-2000 | Dr Andrew James Zganjar, MD 4500 San Pablo Rd S, Jacksonville, FL 32224-1865 Ph: (904) 953-2000 |
News Archive
The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years. This is one of the deadliest cancers, with a five-year survival rate of only 20 percent. However, the survival rate more than doubles if the cancer is identified early.
Microbiology researchers at the University of Georgia studying a soil bacterium have identified a potential mechanism for neurodegenerative diseases.
[Many doctors] are giving up ownership of their practices to become part of hospital-owned practices or larger groups with multiple specialties. ... Young doctors in particular are choosing to work for larger organizations rather than starting their own practices, they say.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
› Verified 5 days ago
Amanda Elizabeth Kahn, MD Urology Medicare: Medicare Enrolled Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Eric Alee Vance Qualkenbush, Urology Medicare: Medicare Enrolled Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Sarah Jessica Hampton, Urology Medicare: Medicare Enrolled Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Daniela Andrea Haehn, MD Urology Medicare: Medicare Enrolled Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Charles Gary Cobb, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 710 Lomax St, Jacksonville, FL 32204 Phone: 904-355-6583 Fax: 904-355-4922 | |
Gregory Broderick, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Dr. Erica S. Mercer, MD Urology Medicare: Medicare Enrolled Practice Location: 807 Childrens Way, Jacksonville, FL 32207 Phone: 904-390-3747 Fax: 904-390-3429 |